Biomolecule-functionalized nanoformulations for prostate cancer theranostics

[1]  Haipeng Yang,et al.  Sarcosine Biosensor Based on Pt/g-C3N4 Nanocomposites with High Electrocatalytic Activity , 2022, ECS Journal of Solid State Science and Technology.

[2]  C. Dufès,et al.  Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells , 2022, International journal of nanomedicine.

[3]  Jianfei Xia,et al.  Synergetic PtNP@Co3O4 hollow nanopolyhedrals as peroxidase-like nanozymes for the dual-channel homogeneous biosensing of prostate-specific antigen , 2022, Analytical and Bioanalytical Chemistry.

[4]  Libin Guo,et al.  Single-atom Pt-anchored Zn0.5Cd0.5S boosted photoelectrochemical immunoassay of prostate-specific antigen. , 2022, Biosensors & bioelectronics.

[5]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[6]  Ninghan Feng,et al.  A dual-readout sandwich immunoassay based on biocatalytic perovskite nanocrystals for detection of prostate specific antigen. , 2022, Biosensors & bioelectronics.

[7]  Dong Ming,et al.  Electrochemical Immunosensor Based on Hybrid MoS2/Pt@Au-nanoprism/PDA for Simultaneous Detection of Free and Total Prostate Specific Antigen in Serum , 2022, Sensors and Actuators B: Chemical.

[8]  Bin Liu,et al.  Tumor Microenvironment pH-Responsive Pentagonal Gold Prism-Based Nanoplatform for Multimodal Imaging and Combined Therapy of Castration-Resistant Prostate Cancer. , 2022, Acta biomaterialia.

[9]  A. Abuzenadah,et al.  Development of (−)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment , 2021, Nanotechnology Reviews.

[10]  Sang Hun Lee,et al.  Lateral Flow Immunoassay with Quantum-Dot-Embedded Silica Nanoparticles for Prostate-Specific Antigen Detection , 2021, Nanomaterials.

[11]  P. Humphrey,et al.  Targeting prostate cancer with clostridium perfringens enterotoxin functionalized nanoparticles co-encapsulating imaging cargo enhances magnetic resonance imaging specificity. , 2021, Nanomedicine : nanotechnology, biology, and medicine.

[12]  M. Zhang,et al.  Simultaneous detection of dual biomarkers using hierarchical MoS2 nanostructuring and nano-signal amplification-based electrochemical aptasensor toward accurate diagnosis of prostate cancer , 2021, Biosensors and Bioelectronics.

[13]  Yue Zheng,et al.  Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer , 2021, Cell proliferation.

[14]  Jiye Cai,et al.  Tumor Targeting and Penetrating Biomimetic Mesoporous Polydopamine Nanoparticles Facilitate Photothermal Killing and Autophagy Blocking for Synergistic Tumor Ablation. , 2021, Acta biomaterialia.

[15]  C. Nachiyar,et al.  Gum acacia PEG iron oxide nanocomposite (GA-PEG-IONC) induced pharmacotherapeutic activity on the Las R gene expression of Pseudomonas aeruginosa and HOXB13 expression of prostate cancer (Pc 3) cell line. A green therapeutic approach of molecular mechanism inhibition. , 2021, International journal of biological macromolecules.

[16]  L. Min,et al.  Evaporation‐Induced rGO Coatings for Highly Sensitive and Non‐Invasive Diagnosis of Prostate Cancer in the PSA Gray Zone , 2021, Advanced materials.

[17]  M. Brocchi,et al.  Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics , 2021, Bioactive materials.

[18]  Jafar Ezzati Nazhad Dolatabadi,et al.  Aptamer functionalized nanomaterials for biomedical applications: Recent advances and new horizons , 2021 .

[19]  L. Ferguson,et al.  Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions , 2021, Scientific reports.

[20]  J. Driskell,et al.  High-Affinity Points of Interaction on Antibody Allow Synthesis of Stable and Highly Functional Antibody-Gold Nanoparticle Conjugates. , 2021, Bioconjugate chemistry.

[21]  Jie Sun,et al.  Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone , 2021, Drug delivery.

[22]  Z. Qian,et al.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles , 2021, Signal Transduction and Targeted Therapy.

[23]  D. Cui,et al.  Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating IGFR/AKT/NF-kB/IkB signaling. , 2021, Biomaterials.

[24]  C. Dufès,et al.  Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro , 2021, International journal of nanomedicine.

[25]  D. Jin,et al.  Stable and Highly Efficient Antibody-Nanoparticles Conjugation. , 2021, Bioconjugate chemistry.

[26]  Junwei Shi,et al.  Prostate Cancer Targeted X-ray Fluorescence Imaging via Gold Nanoparticles Functionalized with Prostate-Specific Membrane Antigen (PSMA). , 2021, International journal of radiation oncology, biology, physics.

[27]  Guannan Chen,et al.  A target-triggered and self-calibration aptasensor based on SERS for precise detection of a prostate cancer biomarker in human blood. , 2021, Nanoscale.

[28]  D. Taïeb,et al.  Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes , 2021, Pharmaceutics.

[29]  J. Gomez-Marquez,et al.  Local development of nanotechnology-based diagnostics , 2021, Nature Nanotechnology.

[30]  Kezhen Yi,et al.  Aptamer-Exosomes for Tumor Theranostics. , 2021, ACS sensors.

[31]  Y. Assaraf,et al.  Targeted nanomedicine modalities for prostate cancer treatment. , 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[32]  Jennifer Thayanne Cavalcante de Araújo,et al.  Nanosystem functionalization strategies for prostate cancer treatment: a review , 2021, Journal of drug targeting.

[33]  Suhair Hikmat,et al.  Colloidal Stability and Cytotoxicity of Polydopamine-Conjugated Gold Nanorods against Prostate Cancer Cell Lines , 2021, Molecules.

[34]  R. Vijayalakshmi,et al.  An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer , 2021, Scientific Reports.

[35]  Nycol M. Cotto,et al.  Milk exosomes: Nature's abundant nanoplatform for theranostic applications , 2021, Bioactive materials.

[36]  R. Montironi,et al.  Treating Prostate Cancer by Antibody–Drug Conjugates , 2021, International journal of molecular sciences.

[37]  Yu-Hsin Lin,et al.  Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer , 2021, Biomedicines.

[38]  G. Shen,et al.  PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics. , 2021, Journal of materials chemistry. B.

[39]  H. Leung,et al.  Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells. , 2020, Biomaterials science.

[40]  K. Saravanakumar,et al.  pH-sensitive release of fungal metabolites from chitosan nanoparticles for effective cytotoxicity in prostate cancer (PC3) cells , 2020 .

[41]  Congcong Zhu,et al.  Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer , 2020, International journal of nanomedicine.

[42]  F. Tadayon,et al.  A novel label-free impedimetric immunosensor for sensitive detection of prostate specific antigen using Au nanoparticles/MWCNTs- graphene quantum dots nanocomposite , 2020 .

[43]  J. Conde,et al.  Localized nanotheranostics: recent developments in cancer nanomedicine , 2020, Materials Today Advances.

[44]  Gennaro Sanità,et al.  Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization , 2020, Frontiers in Molecular Biosciences.

[45]  C. Huang,et al.  Carbon dots-based fluorescence resonance energy transfer for the prostate specific antigen (PSA) with high sensitivity. , 2020, Talanta.

[46]  M. Hasanzadeh,et al.  Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[47]  Yishu Fu,et al.  A novel chemiluminescence imaging immunosensor for prostate specific antigen detection based on a multiple signal amplification strategy. , 2020, Biosensors & bioelectronics.

[48]  A. Jemal,et al.  Cancer statistics for adolescents and young adults, 2020 , 2020, CA: a cancer journal for clinicians.

[49]  E. Arkan,et al.  Fabrication of a novel electrochemical aptasensor assisted by a novel computerized monitoring system for real-time determination of the prostate specific antigen: A computerized experimental method brought elegancy , 2020 .

[50]  V. Awasthi,et al.  Nanoparticles for Targeting of Prostate Cancer. , 2020, Current pharmaceutical design.

[51]  Han Liu,et al.  Electroactive Cu2O nanoparticles and Ag nanoparticles driven ratiometric electrochemical aptasensor for prostate specific antigen detection , 2020 .

[52]  Nicole F. Steinmetz,et al.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications , 2020, Advanced Drug Delivery Reviews.

[53]  Hongying Chen,et al.  Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. , 2020, Acta biomaterialia.

[54]  Yougan Chen,et al.  Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[55]  J. Tkáč,et al.  Ultrasensitive Ti3C2TX MXene/Chitosan Nanocomposite-Based Amperometric Biosensor for Detection of Potential Prostate Cancer Marker in Urine Samples , 2020, Processes.

[56]  Yun Luo,et al.  Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer , 2020, BioMed research international.

[57]  Xiliang Luo,et al.  Construction of efficient "on-off-on" fluorescence aptasensor for ultrasensitive detection of prostate specific antigen via covalent energy transfer between g-C3N4 quantum dots and palladium triangular plates. , 2020, Analytica chimica acta.

[58]  B. Liu,et al.  CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[59]  Yang Song,et al.  Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies. , 2020, Materials today.

[60]  D. He,et al.  Cell Membrane-camouflaged Nanoparticles as Drug Carriers for Cancer Therapy. , 2020, Acta biomaterialia.

[61]  A C Marques,et al.  Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[62]  G. Liang,et al.  Covalently Conjugated Hydrogelators for Imaging and Therapeutic Applications. , 2020, Bioconjugate chemistry.

[63]  Lin Liu,et al.  A colorimetric method for determination of the prostate specific antigen based on enzyme-free cascaded signal amplification via  peptide-copper(II) nanoparticles , 2020, Microchimica Acta.

[64]  W. Rhim,et al.  Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications. , 2019, Methods.

[65]  Xueli Chen,et al.  Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer , 2019, Front. Pharmacol..

[66]  W. Alshaer,et al.  Aptamers Chemistry: Chemical Modifications and Conjugation Strategies , 2019, Molecules.

[67]  G. Zheng,et al.  Nanomedicines Lost in Translation. , 2019, ACS nano.

[68]  E. Papoutsakis,et al.  Extracellular vesicles: exosomes, microparticles, their parts, and their targets to enable their biomanufacturing and clinical applications. , 2019, Current opinion in biotechnology.

[69]  Marc R. Knecht,et al.  Biomolecular Materials Recognition in Two Dimensions: Peptide Binding to Graphene, h-BN and MoS2 Nanosheets as Unique Bioconjugates. , 2019, Bioconjugate chemistry.

[70]  Yuehe Lin,et al.  Integrating ionic liquids with molecular imprinting technology for biorecognition and biosensing: A review. , 2019, Biosensors & bioelectronics.

[71]  H. Leung,et al.  Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. , 2019, Nanoscale.

[72]  J. Carles,et al.  Nanoparticles as theranostic vehicles in prostate cancer. , 2019, Annals of translational medicine.

[73]  D. Tang,et al.  Ti3C2 MXene nanosheet-based capacitance immunoassay with tyramine-enzyme repeats to detect prostate-specific antigen on interdigitated micro-comb electrode , 2019, Electrochimica Acta.

[74]  Jon A. Schwartz,et al.  Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study , 2019, Proceedings of the National Academy of Sciences.

[75]  G. Aliev,et al.  Extracellular vesicles in cancer nanomedicine. , 2019, Seminars in cancer biology.

[76]  S. P. Srinivas,et al.  Current trends and challenges in cancer management and therapy using designer nanomaterials , 2019, Nano Convergence.

[77]  S. Kelley,et al.  Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking. , 2019, Analytical chemistry.

[78]  Yang Wang,et al.  Cellular functions of long noncoding RNAs , 2019, Nature Cell Biology.

[79]  Jun Wei,et al.  Enhanced targeting of prostate cancer-initiating cells by salinomycin-encapsulated lipid-PLGA nanoparticles linked with CD44 antibodies. , 2019, Oncology letters.

[80]  Mingxiong Sheng,et al.  Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. , 2019, Colloids and surfaces. B, Biointerfaces.

[81]  Yali Sun,et al.  Fluorometric nanoprobes for simultaneous aptamer-based detection of carcinoembryonic antigen and prostate specific antigen , 2019, Microchimica Acta.

[82]  Rajender Kumar,et al.  Polydopamine Modified Superparamagnetic Iron Oxide Nanoparticles as Multifunctional Nanocarrier for Targeted Prostate Cancer Treatment , 2019, Nanomaterials.

[83]  J. Benlloch,et al.  PSMA-Targeted Mesoporous Silica Nanoparticles for Selective Intracellular Delivery of Docetaxel in Prostate Cancer Cells , 2019, ACS Omega.

[84]  H. Leung,et al.  Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. , 2018, Nanoscale.

[85]  Yuliang Zhao,et al.  Efficient Near Infrared Light Triggered Nitric Oxide Release Nanocomposites for Sensitizing Mild Photothermal Therapy , 2018, Advanced science.

[86]  Minghua Wang,et al.  Bifunctional aptasensor based on novel two-dimensional nanocomposite of MoS2 quantum dots and g-C3N4 nanosheets decorated with chitosan-stabilized Au nanoparticles for selectively detecting prostate specific antigen. , 2018, Analytica chimica acta.

[87]  R. Kizek,et al.  A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing , 2018, International journal of molecular sciences.

[88]  Gang Zhao,et al.  Simultaneous immunoassays of dual prostate cancer markers using a SERS-based microdroplet channel. , 2018, Biosensors & bioelectronics.

[89]  Eun-Kyung Lim,et al.  Multivalent Antibody-Nanoparticle Conjugates To Enhance the Sensitivity of Surface-Enhanced Raman Scattering-Based Immunoassays. , 2018, ACS applied materials & interfaces.

[90]  Michael J. Morris,et al.  Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial , 2018, JAMA oncology.

[91]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[92]  Jonathan F. Lovell,et al.  Current taxane formulations and emerging cabazitaxel delivery systems , 2018, Nano Research.

[93]  Ki‐Hyun Kim,et al.  A novel approach for amine derivatization of MoS2 nanosheets and their application toward label-free immunosensor. , 2018, Analytical biochemistry.

[94]  Susan Hua,et al.  Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization , 2018, Front. Pharmacol..

[95]  Xiaoying Wang,et al.  Enzyme-Free Immunosorbent Assay of Prostate Specific Antigen Amplified by Releasing pH Indicator Molecules Entrapped in Mesoporous Silica Nanoparticles. , 2018, Analytical chemistry.

[96]  V. Adam,et al.  Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin , 2018, Scientific Reports.

[97]  H. Shmeeda,et al.  Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA). , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[98]  Gaiping Li,et al.  Novel electrochemical biosensor based on cationic peptide modified hemin/G-quadruples enhanced peroxidase-like activity. , 2018, Biosensors & bioelectronics.

[99]  K. Hunter,et al.  Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence , 2018, Nature Communications.

[100]  H. Matsumoto,et al.  Colonic endoscopic mucosal resection in patients taking anticoagulants: Is heparin bridging therapy necessary? , 2018, Journal of digestive diseases.

[101]  J. Basilion,et al.  Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer. , 2018, ACS nano.

[102]  J. Darko,et al.  Synthesis of curcumin-functionalized gold nanoparticles and cytotoxicity studies in human prostate cancer cell line , 2018, Applied Nanoscience.

[103]  B. Dennis,et al.  Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis , 2018, The Annals of Family Medicine.

[104]  Xian-lu Song,et al.  Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging , 2018, RSC advances.

[105]  H. Gallardo,et al.  Heparin‐gold Nanoparticles and Liquid Crystal Applied in Label‐free Electrochemical Immunosensor for Prostate‐specific Antigen , 2018 .

[106]  L. Luyt,et al.  Bombesin‐functionalized water‐soluble gold nanoparticles for targeting prostate cancer , 2017 .

[107]  R. Kizek,et al.  Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery , 2017, Nanomaterials.

[108]  M. Prato,et al.  Targeted killing of prostate cancer cells using antibody-drug conjugated carbon nanohorns. , 2017, Journal of materials chemistry. B.

[109]  C. Huang,et al.  Surface-engineered quantum dots/electrospun nanofibers as a networked fluorescence aptasensing platform toward biomarkers. , 2017, Nanoscale.

[110]  R. Khan,et al.  Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor. , 2017, Analytical biochemistry.

[111]  Jules L. Hammond,et al.  Self-assembled gold nanoparticles for impedimetric and amperometric detection of a prostate cancer biomarker , 2017 .

[112]  P. Babinec,et al.  Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia , 2017, International journal of nanomedicine.

[113]  J. Aragon-Ching,et al.  Role of chemotherapy in prostate cancer , 2017, Asian journal of andrology.

[114]  Kasarla Ramakrushna Reddy,et al.  Development of an electrochemical immunosensor based on gold nanoparticles incorporated chitosan biopolymer nanocomposite film for the detection of prostate cancer using PSA as biomarker. , 2017, Enzyme and microbial technology.

[115]  Xin Yu,et al.  Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer. , 2017, ACS nano.

[116]  C. Esposito,et al.  Aptamer Cell-Based Selection: Overview and Advances , 2017, Biomedicines.

[117]  Jing Qin,et al.  Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment , 2017, Acta pharmaceutica Sinica. B.

[118]  Leigh H. Simmons,et al.  Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection. , 2017, The Medical clinics of North America.

[119]  Pengcheng Zhang,et al.  Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy , 2017, Theranostics.

[120]  S. Muyldermans,et al.  Functionalization of gold nanoparticles with nanobodies through physical adsorption , 2017 .

[121]  N. Zhang,et al.  DNA sequence functionalized with heterogeneous core-satellite nanoassembly for novel energy-transfer-based photoelectrochemical bioanalysis. , 2017, Biosensors & bioelectronics.

[122]  A. Pramanik,et al.  Two-Photon Fluorescent Molybdenum Disulfide Dots for Targeted Prostate Cancer Imaging in the Biological II Window , 2017, ACS omega.

[123]  C. Wilhelm,et al.  Extracellular Vesicle Production Loaded with Nanoparticles and Drugs in a Trade‐off between Loading, Yield and Purity: Towards a Personalized Drug Delivery System , 2017, Advanced biosystems.

[124]  Namhyun Choi,et al.  Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer. , 2017, ACS nano.

[125]  Hung-Wei Yang,et al.  An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide/ssDNA/PLLA nanoparticles. , 2017, Biosensors & bioelectronics.

[126]  Z. Zhou,et al.  Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)–Targeted Photothermal Therapy , 2017, SLAS technology.

[127]  Shuai Zhen,et al.  Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome , 2016, Oncotarget.

[128]  R. Franklin,et al.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. , 2016, Archives of biochemistry and biophysics.

[129]  Jia Lin,et al.  Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy. , 2016, ACS applied materials & interfaces.

[130]  Dongmei Wu,et al.  Prostate cancer targeted multifunctionalized graphene oxide for magnetic resonance imaging and drug delivery , 2016 .

[131]  A. Avan,et al.  Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies , 2016, Cancer Gene Therapy.

[132]  Yuko Nakamura,et al.  Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? , 2016, Bioconjugate chemistry.

[133]  T. Soares,et al.  Impact of the Molecular Environment on Thiol-Ene Coupling For Biofunctionalization and Conjugation. , 2016, Bioconjugate chemistry.

[134]  H. Heli,et al.  Label-free electrochemical aptasensing of the human prostate-specific antigen using gold nanospears. , 2016, Talanta.

[135]  S. Khan,et al.  PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. , 2016, Colloids and surfaces. B, Biointerfaces.

[136]  J. Holmes,et al.  Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells. , 2016, International journal of pharmaceutics.

[137]  Nan Zhang,et al.  Preparation of highly cross-linked raspberry-like nano/microspheres and surface tailoring for controlled immunostimulating peptide adsorption , 2016 .

[138]  V. Adam,et al.  Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells. , 2016, ACS applied materials & interfaces.

[139]  Xiaobing Zhang,et al.  Aptamer-integrated DNA nanostructures for biosensing, bioimaging and cancer therapy. , 2016, Chemical Society reviews.

[140]  W. Fan,et al.  Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo , 2016, Drug delivery.

[141]  Ronnie H. Fang,et al.  Biomimetic strategies for targeted nanoparticle delivery , 2016, Bioengineering & translational medicine.

[142]  L. Egevad,et al.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.

[143]  K. Ye,et al.  A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery , 2016, International journal of molecular sciences.

[144]  Glen J Weiss,et al.  Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors , 2016, Clinical Cancer Research.

[145]  Sharanjot Saini.  PSA and beyond: alternative prostate cancer biomarkers , 2016, Cellular Oncology.

[146]  Abdollah Noorbakhsh,et al.  Sensitive Electrochemical Prostate Specific Antigen Aptasensor: Effect of Carboxylic Acid Functionalized Carbon Nanotube and Glutaraldehyde Linker , 2016 .

[147]  A. Salimi,et al.  Ultrasensitive electrochemical immunosensor for PSA biomarker detection in prostate cancer cells using gold nanoparticles/PAMAM dendrimer loaded with enzyme linked aptamer as integrated triple signal amplification strategy. , 2015, Biosensors & bioelectronics.

[148]  M. Cooperberg,et al.  Genomic Predictors of Outcome in Prostate Cancer. , 2015, European urology.

[149]  Michael S. Strano,et al.  Protein functionalized carbon nanomaterials for biomedical applications , 2015 .

[150]  M. Pomper,et al.  Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues , 2015, Molecular Cancer Therapeutics.

[151]  Fengli Gao,et al.  A fluorescence active gold nanorod–quantum dot core–satellite nanostructure for sub-attomolar tumor marker biosensing , 2015 .

[152]  P. Searson,et al.  Diagnosis of prostate cancer via nanotechnological approach , 2015, International journal of nanomedicine.

[153]  Y. Nam,et al.  Genetically Programmed Clusters of Gold Nanoparticles for Cancer Cell-Targeted Photothermal Therapy. , 2015, ACS applied materials & interfaces.

[154]  A. Boccaccini,et al.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review , 2015, Journal of The Royal Society Interface.

[155]  Glenn P. Goodrich,et al.  Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[156]  Q. Wei,et al.  3D sandwich-type prostate specific antigen (PSA) immunosensor based on rGO–MWCNT–Pd nanocomposite , 2015 .

[157]  Vojtech Adam,et al.  Paramagnetic Nanoparticles as a Platform for FRET-Based Sarcosine Picomolar Detection , 2015, Scientific Reports.

[158]  L. Robert.  Hyaluronan, a truly "youthful" polysaccharide. Its medical applications. , 2015, Pathologie-biologie.

[159]  W. Fan,et al.  Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo , 2014, International journal of nanomedicine.

[160]  Jian Wang,et al.  Biomolecules-conjugated nanomaterials for targeted cancer therapy. , 2014, Journal of materials chemistry. B.

[161]  C. Ban,et al.  Ultra-effective photothermal therapy for prostate cancer cells using dual aptamer-modified gold nanostars. , 2014, Journal of materials chemistry. B.

[162]  B. Godin,et al.  Internalization of Red Blood Cell-Mimicking Hydrogel Capsules with pH-Triggered Shape Responses , 2014, ACS nano.

[163]  L. Curiel,et al.  Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging , 2014, PloS one.

[164]  Tianjiao Ji,et al.  Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment. , 2014, ACS nano.

[165]  Kuo Zhang,et al.  Messenger RNA vaccine based on recombinant MS2 virus‐like particles against prostate cancer , 2014, International journal of cancer.

[166]  Q. Ma,et al.  A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells. , 2014, Analytica chimica acta.

[167]  Stavroula Sofou,et al.  Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer , 2014, The Journal of Nuclear Medicine.

[168]  Penglei Chen,et al.  Highly Stable Graphene‐Based Multilayer Films Immobilized via Covalent Bonds and Their Applications in Organic Field‐Effect Transistors , 2013 .

[169]  B. Melichar.  PSA, PCA3 and the phi losophy of prostate cancer management , 2013, Clinical chemistry and laboratory medicine.

[170]  Weihong Tan,et al.  Aptamers from cell-based selection for bioanalytical applications. , 2013, Chemical reviews.

[171]  Dan Wu,et al.  Label-free electrochemical immunosensor for prostate-specific antigen based on silver hybridized mesoporous silica nanoparticles. , 2013, Analytical biochemistry.

[172]  Sarit S. Agasti,et al.  Gold nanoparticles in chemical and biological sensing. , 2012, Chemical reviews.

[173]  Hong Yan Song,et al.  Comparative study of random and oriented antibody immobilization as measured by dual polarization interferometry and surface plasmon resonance spectroscopy. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[174]  R. Langer,et al.  Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. , 2012, ACS nano.

[175]  F. Aragona,et al.  PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsy. , 2011, Anticancer research.

[176]  Ho-Keun Kwon,et al.  Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[177]  W. Fan,et al.  Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy , 2011, International journal of nanomedicine.

[178]  Y. Jeong,et al.  Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. , 2011, Small.

[179]  Sarat Chandarlapaty,et al.  Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. , 2011, Cancer cell.

[180]  M. Veerapandian,et al.  Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications , 2011, Applied Microbiology and Biotechnology.

[181]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[182]  J. Machiels,et al.  Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial , 2010, The Lancet.

[183]  R. Sperling,et al.  Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[184]  A. Kibel.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2009 .

[185]  William Berry,et al.  Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[186]  史惠蓉,et al.  Robert: , 2009, Oral Histories of Older Gay Men in Hong Kong.

[187]  Robert Langer,et al.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.

[188]  R. Murray.  Nanoelectrochemistry: Metal Nanoparticles, Nanoelectrodes, and Nanopores , 2008 .

[189]  Y Charles Cao,et al.  Nanomaterials for biomedical applications. , 2008, Nanomedicine.

[190]  K. Hamad-Schifferli,et al.  Structure and function of nanoparticle–protein conjugates , 2008, Biomedical materials.

[191]  Rodolfo Montironi,et al.  Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. , 2007, European urology.

[192]  K. Shinohara.  Improving cancer detection by prostate biopsy: the role of core number and site , 2006, Nature Clinical Practice Urology.

[193]  R. Bandelloni,et al.  Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsy. , 2006, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[194]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[195]  W. Catalona,et al.  Characteristics of prostate cancer detected by digital rectal examination only. , 2006, Urology.

[196]  Challa S. S. R. Kumar,et al.  Biofunctionalization of nanomaterials , 2005 .

[197]  Omid C. Farokhzad,et al.  Nanoparticle-Aptamer Bioconjugates , 2004, Cancer Research.

[198]  C. Tangen,et al.  Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. , 2004, The New England journal of medicine.

[199]  I. Tannock,et al.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. , 2004, The New England journal of medicine.

[200]  J. Crowley,et al.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. , 2004, The New England journal of medicine.

[201]  M. Zheng,et al.  Ethylene glycol monolayer protected nanoparticles: synthesis, characterization, and interactions with biological molecules. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[202]  R. Naaman,et al.  Confocal Fluorescence Imaging of DNA-Functionalized Carbon Nanotubes , 2003 .

[203]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[204]  Debashis Ghosh,et al.  alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.

[205]  H. D. de Koning,et al.  Prostate cancer detection at low prostate specific antigen. , 2000, The Journal of urology.

[206]  C. Ling,et al.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[207]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[208]  J. Richie,et al.  COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE CANCER: RESULTS OF A MULTICENTER CLINICAL TRIAL OF 6,630 MEN , 1994, The Journal of urology.

[209]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[210]  R. Reed,et al.  Hyaluronan in the rat with special reference to the skin. , 1988, Acta physiologica Scandinavica.

[211]  S. Faintuch,et al.  Nanotheranostics in oncology and drug development for imaging and therapy , 2020 .

[212]  Qaneeta Haseeb,et al.  Nanobiotechnology: Paving the Way to Personalized Medicine , 2020 .

[213]  Xinru You,et al.  Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives. , 2019, Current topics in medicinal chemistry.

[214]  D. He,et al.  Cell Membrane-Camouflaged Nanoparticles as Drug Carriers for Cancer Therapy , 2019, SSRN Electronic Journal.

[215]  Pranav Tiwari,et al.  The combined effect of thermal and chemotherapy on HeLa cells using magnetically actuated smart textured fibrous system. , 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

[216]  M. Hallek.  Prostate Cancer , 2018, Springer International Publishing.

[217]  C. Chuang,et al.  Co-Delivery of Docetaxel and p44/42 MAPK siRNA Using PSMA Antibody-Conjugated BSA-PEI Layer-by-Layer Nanoparticles for Prostate Cancer Target Therapy. , 2017, Macromolecular bioscience.

[218]  F. Mi,et al.  EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment. , 2016, Nanomedicine.

[219]  Feng Zhang,et al.  Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.

[220]  M. Sotomayor,et al.  [Overdiagnosis in prostate cancer]. , 2014, Archivos espanoles de urologia.

[221]  R. Autorino,et al.  Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3. , 2011, European urology.

[222]  L. Schaefer,et al.  Proteoglycans: from structural compounds to signaling molecules , 2009, Cell and Tissue Research.